Micro-Tech (Nanjing) Co.,Ltd (SHA:688029)
China
· Delayed Price · Currency is CNY 66.49
+0.62 (0.94%)
May 23, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Hemostasis and Closure | 921.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hemostasis and Closure Growth | 27.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopic Mucosal Resection/Endoscopic Submucosal Dissection Class | 350.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopic Mucosal Resection/Endoscopic Submucosal Dissection Class Growth | 37.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopsy Class | 246.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopsy Class Growth | -1.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Expansion Class | 212.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Expansion Class Growth | 13.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Microwave Ablation Needle | 174.04M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Microwave Ablation Needle Growth | 41.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopic Retrograde Cholangiopancreatography Class | 172.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopic Retrograde Cholangiopancreatography Class Growth | 57.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Visual Product | 97.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Visual Product Growth | -48.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Proxy | 89.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Proxy Growth | 67.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopic Ultrasonography/Endobronchial Ultrasound Class | 43.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopic Ultrasonography/Endobronchial Ultrasound Class Growth | 82.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 102.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 63.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tumor Ablation Device | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tumor Ablation Device Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 1.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 18.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 1.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 25.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|